AVTR logo

Avantor, Inc. Stock Price

NYSE:AVTR Community·US$8.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

AVTR Share Price Performance

US$11.74
-9.30 (-44.20%)
US$17.65
Fair Value
US$11.74
-9.30 (-44.20%)
38.2% undervalued intrinsic discount
US$19.00
Fair Value
Price US$11.74
AnalystHighTarget US$19.00
AnalystConsensusTarget US$13.64
AnalystLowTarget US$12.00

AVTR Community Narratives

AnalystHighTarget·
Fair Value US$17.65 33.5% undervalued intrinsic discount

Secular Trends And Cell Therapies Will Expand Markets Despite Risks

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$13.64 13.9% undervalued intrinsic discount

AVTR: Activist Pressure And Business Overhaul Will Drive Share Recovery

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AnalystLowTarget·
Fair Value US$12 2.2% undervalued intrinsic discount

Digital Transformation And Rising Costs Will Undermine Lab Chemicals Sector

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$13.64
13.9% undervalued intrinsic discount
Revenue
2% p.a.
Profit Margin
12.68%
Future PE
13.62x
Price in 2028
US$17.59

Updated Narratives

AVTR logo

AVTR: Activist Pressure And Business Overhaul Will Drive Share Recovery

Fair Value: US$13.64 13.9% undervalued intrinsic discount
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AVTR logo

Secular Trends And Cell Therapies Will Expand Markets Despite Risks

Fair Value: US$17.65 33.5% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AVTR logo

Digital Transformation And Rising Costs Will Undermine Lab Chemicals Sector

Fair Value: US$12 2.2% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with moderate growth potential.

1 Risk
3 Rewards

Avantor, Inc. Key Details

US$6.6b

Revenue

US$4.4b

Cost of Revenue

US$2.2b

Gross Profit

US$2.3b

Other Expenses

-US$82.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.12
33.13%
-1.25%
68.8%
View Full Analysis

About AVTR

Founded
1904
Employees
13500
CEO
Emmanuel Ligner
WebsiteView website
www.avantorsciences.com

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Recent AVTR News & Updates

Recent updates

No updates